1. Home
  2. SPCB vs FLNA Comparison

SPCB vs FLNA Comparison

Compare SPCB & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$9.32

Market Cap

56.2M

Sector

Technology

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

BUY

Current Price

$0.65

Market Cap

61.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
SPCB
FLNA
Founded
1988
1998
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.2M
61.8M
IPO Year
2004
2000

Fundamental Metrics

Financial Performance
Metric
SPCB
FLNA
Price
$9.32
$0.65
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
★ $17.00
$6.50
AVG Volume (30 Days)
49.2K
★ 702.8K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $41,119,000.00
Revenue This Year
$9.51
N/A
Revenue Next Year
$12.31
N/A
P/E Ratio
$10.36
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.07
$0.64
52 Week High
$12.87
$2.03

Technical Indicators

Market Signals
Indicator
SPCB
FLNA
Relative Strength Index (RSI) 49.54 34.93
Support Level $8.75 N/A
Resistance Level $9.58 $1.05
Average True Range (ATR) 0.45 0.04
MACD 0.05 -0.02
Stochastic Oscillator 75.13 3.74

Price Performance

Historical Comparison
SPCB
FLNA

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: